Abstract
There is not any doubt that the SCT procedure involves important ethical and legal aspects. The expectations of patients concerning the quality of life and the new way of treatment are certainly an important motivation for researchers and physicians. Societies in Europe seem to accept the idea of using their own or allogeneic stem cells for tissue engineering and transplantation. A physician should be aware of the standards established by tradition and act within the general principles that have governed professional conduct. The International Code of Ethics and the Declaration of Geneva (1948), developed and approved by the World Medical Association, have modernized the ancient codes. They have been endorsed by each member organization, including The Polish Medical Association, as a general guide with nationwide application. The Polish Chamber of Physicians accepts the responsibility of delineating the standard of ethical behavior expected of Polish physicians. An interpretation of the principles concerning SCT is developed in the following pages as a guide for individual SCT physicians.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Doran D . Methodology of conducting academic clinical trials in Europe. In: Apperley A, Carreras E, Glucmann A, Gratwohl, Masszi T (eds). The EBMT Handbook 5th edn Hematopoietic Stem Cell Transplantation 2008, pp 340–355.
Gajewski JL, Foote M, Tietjen J, Nelson B, Simons A, Champlin R . Blood and marrow transplantation compensation: perspective in payer and provider relations. Biol Blood and Marrow Transplant 2004; 10: 427–432.
Chervenak Frank A, Mc Cullough Laurence B, Knapp Robert C, Caputo Thomas A, Barber Hugh RK . A clinically comprehensive ethical framework for offering and recommending cancer treatment before and during pregnancy. Cancer 2004; 100: 215–222.
Wroński K . The obligation of doctors to inform patients about the risk and results of surgical procedure. Polish Oncol 2008; 11: 26–28.
Lexchin J, Bero LA, Djulbegovic B, Clark O . Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003; 326: 1167–1170.
Górski Andrzej (ed). Science and Engineering Ethics. 2002; 8: 257–480; Special issue: conflict of interest and its significance in science and medicine. The Proceedings of an International Conference held in Warsaw, Poland, 5–6 April 2002.
Lannon CM . Principles for the development and use of quality measures. Pediatrics 2008; 121: 411–418.
Markman M, DeMarco J . Potential conflict between fundamental ethical principles and requirements of the oncology drug approval process. Cancer 2003; 98: 215--328.
Moreno M, Fost N, Christakis D . Research ethics in the MySpace era. Pediatrics 2008; 121: 157–161.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chybicka, A. Quality of life and ethical and legal dilemmas in children during and after hematopoietic SCT procedure. Bone Marrow Transplant 42 (Suppl 2), S87–S89 (2008). https://doi.org/10.1038/bmt.2008.291
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2008.291